(Q42907840)

10 November 2017

title

A pilot trial of memantine and riluzole in ALS: correlation to CSF biomarkers (English)

1 reference

10 November 2017

A pilot trial of memantine and riluzole in ALS: Correlation to CSF biomarkers (English)

1 reference

https://api.crossref.org/works/10.3109/17482968.2010.513052

amyotrophic lateral sclerosis

12 July 2024

main subject

1 reference

1 reference

Robert Bowser

2

1 reference

10 November 2017

Nicole Hank

3

1 reference

10 November 2017

David Saperstein

4

1 reference

10 November 2017

Todd D. Levine

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20839903

12 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20839903

12 July 2024

publication date

14 September 2010

1 reference

full work available at URL

10 November 2017

http://www.tandfonline.com/doi/pdf/10.3109/17482968.2010.513052

1 reference

https://api.crossref.org/works/10.3109/17482968.2010.513052

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

12 July 2024

published in

1 reference

10 November 2017

volume

11

1 reference

10 November 2017

issue

6

1 reference

10 November 2017

page(s)

514-519

1 reference

Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism

10 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Current hypotheses for the underlying biology of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Immunocytochemical and ultrastructural studies of lower motor neurons in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Axonal damage markers in cerebrospinal fluid are increased in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Longitudinal stability of CSF tau levels in Alzheimer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

21 January 2018

1

1 reference

https://api.crossref.org/works/10.3109/17482968.2010.513052

Acta Neurologica Scandinavica

12 July 2024

8

111

1114

Jiminez FJJ

2005

1 reference

https://api.crossref.org/works/10.3109/17482968.2010.513052

Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

12 July 2024

14

1 reference

https://api.crossref.org/works/10.3109/17482968.2010.513052

Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis

12 July 2024

15

1 reference

https://api.crossref.org/works/10.3109/17482968.2010.513052

12 July 2024

Identifiers

1 reference

10 November 2017

1 reference